Getsios, Denis; Blume, Steve; Ishak, K. Jack.; … - In: PharmacoEconomics 28 (2010) 5, pp. 411-427
Background: Recommendations in the UK suggest restricting treatment of Alzheimer's disease with cholinesterase inhibitors, on cost-effectiveness grounds, to patients with moderate cognitive decline. As the economic analyses that informed these recommendations have been the subject of debate, we...